risks of taking semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights The Wegovy Pill for Men:

For a given rise in plasma glucose concentration, the increase in plasma insulin is roughly threefold times greater, if glucose is administered orally compared to intravenous route (Perley and Kipnis, 1967)

Clinical Evidence: What Studies Show About GLP-1 and Heart Health The SUSTAIN-6 trial, a landmark study published in 2016, examined semaglutide's cardiovascular effects in people with type 2 diabetes and existing heart disease or high risk

Short-acting GLP-1RAs, which present a half-life of 34 h, include exenatide, administered twice daily, and lixisenatide, administered once daily, are both exendin-4 derivatives

doi:10 Husain M, Birkenfeld AL, Donsmark M, et al

You don't want a vial that is too big to get through